Enabling Innovation
Alzheimer’s Disease
Commissioning considerations report
tile, title-fs-24px, description-fs-16px, ctatarget-sametab, ctaexitinterstitial-select
White paper document serving as a business case for cerebrospinal fluid (CSF) testing adoption, covering clinical rationale, operational setup, and cost implications.
Alzheimer’s Disease
Toolkit
tile, title-fs-24px, description-fs-16px, ctatarget-sametab, ctaexitinterstitial-select
Provides a practical framework to launch or expand a CSF service, including SOPs, patient leaflets, and setup templates sourced from active NHS sites.
Alzheimer’s Disease
Cost consequence model
tile, title-fs-24px, description-fs-16px, ctatarget-sametab, ctaexitinterstitial-select
Model that calculates the costs of introducing a customisable CSF service pathway using national reference data.
Alzheimer’s Disease
Service planning model
tile, title-fs-24px, description-fs-16px, ctatarget-sametab, ctaexitinterstitial-select
Enables assessment for demand and capacity concerns surrounding introduction of CSF services, most appropriate for sites where service maps is not yet available.
Alzheimer’s Disease
Pathway understanding report
tile, title-fs-24px, description-fs-16px, ctatarget-sametab, ctaexitinterstitial-select
Reports summarising the findings from the Collaborative working project – Improving early accurate diagnosis of Alzheimer's Disease through Cerebrospinal fluid testing, including pathway maps, service setup, costings and patient experience across four NHS trusts.
Cardiometabolic Health
NHS Confederation Report
tile, title-fs-24px, description-fs-16px, ctatarget-sametab, ctaexitinterstitial-select
Developed in collaboration with the NHS Confederation, the report “When Opportunity Knocks: Transforming Weight Management” identifies five key barriers to improving weight management services.
Cardiometabolic Health
In Progress: Toolkit
tile, title-fs-24px, description-fs-16px, ctatarget-sametab, ctaexitinterstitial-select
A step‑by‑step toolkit enabling scalable HbA1c Point-of-Care Testing to improve diabetes outcomes in underserved populations.
Our Donations of Service: PARM tool
PARM (Pro-Active Register Management) is a tool developed in 2018 by Lilly in partnership with the NHS to help GP practices identify patients with type 2 diabetes who require treatment reviews, grouping them into manageable cohorts. Building on this, we now offer a PARM Obesity version to support structured care in obesity management.
This simple-to-use population health management tool enables clinical teams to:
- Transition from ad-hoc patient care to a structured population health approach
- Identify potential patient safety issues
- Improve resource utilisation and capacity planning
- Allocate skill sets to the right patient cohorts
- Organise virtual or in-practice clinics around specific cohorts
- Foster collaboration between primary and secondary care, leaving a legacy of shared learning from specialists
All tools are non-promotional and reflect our commitment to transparency, with services provided as signed donations and fully reported through Transfer of Value submissions to the ABPI, ensuring clear and agreed documentation. Any NHS colleague, whether at national level, within an Integrated Care Board (ICB), a Primary Care Network (PCN), or any healthcare professional, is welcome to contact our team to explore how these tools can support their specific needs.